comparemela.com
Latest Breaking News On - Narcolepsy symptoms while - Page 1 : comparemela.com
Axsome Therapeutics Announces Results of CRESCENDO Narcolepsy Patient Survey Demonstrating Unmet Needs in Treated Narcolepsy Type 1 Patients
77% of narcolepsy type 1 patients continue to experience cataplexy attacks despite being treated 64% of narcolepsy type 1 patients continue to experience excessive daytime sleepiness, as assessed.
United-states
United-kingdom
Philadelphia
Pennsylvania
New-york
British
Karl-doghramji
Darren-opland
Mark-jacobson
Nasdaq
Axsome-therapeutics-inc
Narcolepsy-network
vimarsana © 2020. All Rights Reserved.